Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors

Neuropsychopharmacology

Volumn 32, Issue 2, 2007, Pages 377-387

  Zhang, Xiuwu ^a   Lee, Tong H ^a   Davidson, Colin ^a   Lazarus, Cindy ^a   Wetsel, William C ^a   Ellinwood, Everett H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Behavioral sensitization; Cocaine; GluR1 subunit; NR2B subunit; Ondansetron; Pergolide

Indexed keywords

COCAINE; GLUTAMATE RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; ONDANSETRON; PERGOLIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN LEVEL; COCAINE DEPENDENCE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; MALE; MONOTHERAPY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG THERAPY, COMBINATION; GLUTAMIC ACID; MALE; NEURONS; NUCLEUS ACCUMBENS; ONDANSETRON; PERGOLIDE; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 33846204732     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301101     Document Type: Article

References (63)

1. Arnt J (1985). Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Eur J Pharmacol 113: 79-88.
2. Banke TG, Bowie D, Lee H, Huganir RL, Schousboe A, Traynelis SF (2000). Control of GluR1 AMPA receptor function by cAMPdependent protein kinase. J Neurosci 20: 89-102.
3. Blandina P, Goldfarb J, Craddock-Royal B, Green JP (1989). Release of endogenous dopamine by stimulation of 5-hydroxytruptamine 3 receptors in rat stiatum. J Pharmacol Exp Ther 251: 803-809.
4. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Chen J, Paredes W, Van Praag HM, Lowinson JH. Gardner EL (1992). Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse 10: 264-266.
6. Churchill L, Swanson CJ, Urbina M, Kalivas PW (1999). Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem 72: 2397-2403.
7. Clark BA, Cull-Candy SG (2002). Activity-dependent recruitment of extrasynaptic NMDA receptor activation at an AMPA receptor-only synapse. J Neurosci 22: 4428-4436.
8. Clemens JA, Okimura T, Smalstig EB (1993). Dopamine agonist activities of pergolide, its metabolites and bormocriptine as measured by prolactin inhibition, compulsive turning and stereotypic behavior. Arzneimittel- Forschung 43: 281-286.
9. Cornish JW, O'Brien CP (1996). Crack cocaine abuse: an epidemic with many public health consequences. Annu Rev Public Health 17: 259-273.
10. Davidson C, Lazarus C, Lee TH, Ellinwood EH (2004). Ondansetron, given during the acute cocaine withdrawal, attenuates oral cocaine self-administration. Eur J Pharm 503: 99-102.
11. Davidson C, Lee TH, Xiong Z, Ellinwood EH (2002). Ondansetron given either in the acute or chronic withdrawal from repeated cocaine sensitization dosing regimens reverses the expression of sensitization and inhibits self-administration. Neuropsychopharmacology 27: 542-553.
12. De Deurwaerdere P, Stinus L, Spampinato U (1998). Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J Neurosci 18: 6528-6538.
13. Derkach V, Barria A, Soderling TR (1999). Ca2+/calmodulinkinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA 96: 3269-3274.
14. Ellinwood EH, Balster RL (1974). Rating the behavioral effects of amphetamine. Eur J Pharmacol 28: 35-41.
15. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ (1996). Drugs of abuse and stress increase the expression of gluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptation among cross-sensitizing agents. J Neurosci 16: 274-282.
16. Gainetdinov RR, Mohn AR, Bohn LM, Caron MG (2001). Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci USA 98: 11047-11054.
17. Gavioli EC, Canteras NS, DeLima TC (1999). Amxiogenic-like effects induced by Substance P injected into the lateral septal nucleus. Neuro Report 10: 3399-3403.
18. Gawin FH, Ellinwood EH (1988). Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med 318: 1173-1182.
19. Hollmann M, Heinemann S (1994). Cloned glutamate receptors. Annu Rev Neurosci 17: 31-108.
20. Jakab RL, Goldman-Rakic PS (1998). 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95: 735-740.
21. Jakab RL, Goldman-Rakic PS (2000). Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol 417: 337-348.
22. Kalivas PW, Volkow N, Seamans J (2005). Unmanageable motivation in addiction: a path in prefrontal-accumbens glutamate transport. Neuron 45: 647-650.
23. Kalluri SG, Ticku MK (1999). Potential involvement of tyrosine kinase pathway in the antagonist induced up regulation of the NMDA receptor NR2B subunit in cortical neurons. Mol Brain Res 65: 206-210.
24. Kampman KM, Alterman AI, Volpicelli VR, Maany I, Muller ES, Luce DD et al(2001). Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict 15: 52-59.
25. Karler R, Calder LD, Bedingfield JB (1994). Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology 115: 305-310.
26. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989). Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci 45: 599-606.
27. Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129.
28. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL (2000). Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405: 955-959.
29. Levin FR, McDowell D, Evans SM, Brooks D, Spano C, Nunes EV (1999). Pergolide mesylate for cocaine abuse: a controlled preliminary trial. Am J Addict 8: 120-127.
30. Li Y, White FJ, Wolf ME (2000). Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology 151: 175-183.
31. Li Y, Wolf ME, White FJ (1997). Co-administration of the NMDA receptor antagonist MK-801 with the dopamine D2 receptor agonist quinpirole reverses behavioral sensitization to cocaine. Soc Neurosci Abstr 23: 261-271.
32. Loftis JM, Janowsky A (2002). Cocaine treatment- and withdrawalinduced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit. Psychopharmacology 164: 349-359.
33. Loftis JM, Janowsky A (2003). The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97: 55-85.
34. Lyon M, Randrup A (1972). The dose-response effect of amphetamine upon avoidance behaviour in the rat seen as a function of increasing stereotypy. Psychopharmacologia 23: 334-347.
35. Malcolm R, Hutto BR, Phillips JD, Ballenger JC (1991). Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry 52: 39-40.
36. Malcolm R, Kajdasz DK, Herron J, Anton RF, Brady KT (2000). A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend 60: 161-168.
37. Malcolm R, Moore JW, Kajdasz DK, Ballenger JC (1994). A comparison of pergolide and bromocriptine in the initial rehabilitation of cocaine dependence. Am J Addict 3: 144-147.
38. Moon IS, Apperson ML, Kennedy MB (1994). The major tyrosinephosphorylated protein in the postsynaptic density fraction is Nmethyl-D-aspartate receptor subunit 2B. Proc Natl Acad Sci USA 91: 3954-3958.
39. Mulvaney FD, Alterman AI, Boardman CR, Kampman K (1999). Cocaine abstinence symptomatology and treatment attrition. J Sub Abuse Treat 16: 129-135.
40. Nakanishi S (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258: 597-603.
41. Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K et al(2001). Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem 276: 693-699.
42. Nestler EJ, Hope BT, Widnell KL (1993). Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11: 995-1006.
43. Olanow CW, Watts RL, Koller WC (2001). An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 56(Suppl 5): S1-S88.
44. Omkumar RV, Kiely MJ, Rosenstein AJ, Min KT, Kennedy MB (1996). Identification of a phosphorylation site for calcium/calmodulin dependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 271: 31670-31678.
45. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA.
46. Pierce RC, Kalivas PW (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25: 192-216.
47. 3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Ltr 306: 81-84.
48. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18: 247-291.
49. Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL (1996). Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16: 1179-1188.
50. Scheggi S, Mangiavacchi S, Masi F, Gambarana C, Tagliamonte A, Montis MGDE (2002). Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects. Neuroscience 109: 267-274.
51. Seeburg PH (1993). The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 16: 359-365.
52. Smart TG (1997). Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr Opin Neurobiol 7: 358-367.
53. Smith DA, Browning M, Dunwiddie TV (1993). Cocaine inhibits hippocampal long-term potentiation. Brain Res 608: 259-265.
54. Snyder GL, Allen PB, Fienberg AA, Valle CG, Huganir RL, Nairn AC et al(2000). Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neurosci 20: 4480-4488.
55. Staedt J, Huneriager H, Ruther E, Stoppe G (1998). Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal Myoclonus syndrome (NMS). Longterm follow up on pergolide. J Neural Transm 105: 265-268.
56. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001). Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411: 583-587.
57. Vincent SL, Khan Y, Benes FM (1995). Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 19: 112-120.
58. Westphal RS, Tavalin SJ, Lin JW, Alto NM, Fraser IDC, Langeberg LK (1999). Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 285: 93-96.
59. Witkin JM, Nichols DE, Terry P, Katz JL (1991). Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257: 706-713.
60. Wolf ME (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54: 679-720.
61. Wolf ME (2002). Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol Interv 2: 146-157.
62. Wolf ME, Mangiavacchi S, Sun X (2003). Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann NY Acad Sci 1003: 241-249.
63. Yamaguchi M, Suzuki T, Abe S, Hori T, Kurita H, Asada T et al(2002). Repeated cocaine administration differentially affects NMDA receptor subunit (NR1, NR2A-C) mRNAs in rat brain. Synapse 46: 157-169.